The Impact of Hepatitis C Virus (HCV) Treatment with Direct-Acting (DAA) on the Incidence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Liver Disease

por De Comarmond, Charles, Bajillan, Hendren, Guest, Bailey
Publicado 2017

U.S. Multicenter Pilot Study of Daily Consensus Interferon (CIFN) Plus Ribavirin for “Difficult-to-Treat” HCV Genotype 1 Patients

por Ho, Samuel B., Aqel, Bashar, Dieperink, Eric, Liu, Shanglei, Tetrick, Lori, Falck-Ytter, Yngve, DeComarmond, Charles, Smith, Coleman I., McKee, Daniel P., Boyd, William, Kulig, Clark C., Bini, Edmund J., Pedrosa, Marcos C.
Publicado 2011